Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis

Background and objectives. The clinical course of myasthenia gravis (MG) varies and may adversely affect quality of life and limit daily activities. Repetitive nerve stimulation (RNS) can be used to diagnose MG and may predict disease progression. We aim to establish the correlation between RNS and...

Full description

Bibliographic Details
Main Authors: Pricilla Yani Gunawan, Sindy Chai, Reza Stevano
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2023-09-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://rjn.com.ro/articles/2023.3/RJN_2023_3_Art-02.pdf
_version_ 1797354106436714496
author Pricilla Yani Gunawan
Sindy Chai
Reza Stevano
author_facet Pricilla Yani Gunawan
Sindy Chai
Reza Stevano
author_sort Pricilla Yani Gunawan
collection DOAJ
description Background and objectives. The clinical course of myasthenia gravis (MG) varies and may adversely affect quality of life and limit daily activities. Repetitive nerve stimulation (RNS) can be used to diagnose MG and may predict disease progression. We aim to establish the correlation between RNS and pharmacological treatment response. Materials and methods. We conducted a cross-sectional study evaluating the correlation between RNS result and pharmacological treatment response as evaluated using the Myasthenia Gravis-Activities of Daily Living (MG-ADL). Results. RNS positive patients possess greater severity on pre-treatment (9 [5-11] vs. 4 [2-5], p<0.001) and post-treatment (2 [1-4] vs. 1 [0-2], p=0.007) MG-ADL scores. ∆MG-ADL was also significantly greater in RNS positive patients (-6[-7- -3) vs. -2 [-5 - -1], p=0.004). Spearman’s rank-order correlation conducted evaluating the correlation between RNS and ∆MG-ADL demonstrates a significant moderate positive correlation between RNS and ∆MG-ADL (rs=0.495, p<0.001). Conclusions. A moderate significant correlation was found between RNS and pharmacological treatment response. RNS positive patients are more responsive towards treatment compared to RNS negative patients. Higher fatigability in muscles translates to greater RNS decrements and clinical severity, lending itself to a greater opportunity for improvement following pharmacological. However, this must not be confused with long-term prognosis.
first_indexed 2024-03-08T13:40:29Z
format Article
id doaj.art-ab2a9f38838c4b4e98936642e0d99b7f
institution Directory Open Access Journal
issn 1843-8148
2069-6094
language English
last_indexed 2024-03-08T13:40:29Z
publishDate 2023-09-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Neurology
spelling doaj.art-ab2a9f38838c4b4e98936642e0d99b7f2024-01-16T10:44:35ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942023-09-0122318619010.37897/RJN.2023.3.2Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravisPricilla Yani Gunawan0Sindy Chai1Reza Stevano2Department of Neurology, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia; Department of Neurology, Siloam Hospitals Lippo Village, Tangerang, Banten, Indonesia Department of Neurology, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, IndonesiaDepartment of Neurology, Siloam Hospitals Lippo Village, Tangerang, Banten, Indonesia Background and objectives. The clinical course of myasthenia gravis (MG) varies and may adversely affect quality of life and limit daily activities. Repetitive nerve stimulation (RNS) can be used to diagnose MG and may predict disease progression. We aim to establish the correlation between RNS and pharmacological treatment response. Materials and methods. We conducted a cross-sectional study evaluating the correlation between RNS result and pharmacological treatment response as evaluated using the Myasthenia Gravis-Activities of Daily Living (MG-ADL). Results. RNS positive patients possess greater severity on pre-treatment (9 [5-11] vs. 4 [2-5], p<0.001) and post-treatment (2 [1-4] vs. 1 [0-2], p=0.007) MG-ADL scores. ∆MG-ADL was also significantly greater in RNS positive patients (-6[-7- -3) vs. -2 [-5 - -1], p=0.004). Spearman’s rank-order correlation conducted evaluating the correlation between RNS and ∆MG-ADL demonstrates a significant moderate positive correlation between RNS and ∆MG-ADL (rs=0.495, p<0.001). Conclusions. A moderate significant correlation was found between RNS and pharmacological treatment response. RNS positive patients are more responsive towards treatment compared to RNS negative patients. Higher fatigability in muscles translates to greater RNS decrements and clinical severity, lending itself to a greater opportunity for improvement following pharmacological. However, this must not be confused with long-term prognosis.https://rjn.com.ro/articles/2023.3/RJN_2023_3_Art-02.pdfmyasthenia gravistreatment responserepetitive nerve stimulation
spellingShingle Pricilla Yani Gunawan
Sindy Chai
Reza Stevano
Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
Romanian Journal of Neurology
myasthenia gravis
treatment response
repetitive nerve stimulation
title Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
title_full Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
title_fullStr Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
title_full_unstemmed Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
title_short Repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
title_sort repetitive nerve stimulation as a predictor of treatment response in myasthenia gravis
topic myasthenia gravis
treatment response
repetitive nerve stimulation
url https://rjn.com.ro/articles/2023.3/RJN_2023_3_Art-02.pdf
work_keys_str_mv AT pricillayanigunawan repetitivenervestimulationasapredictoroftreatmentresponseinmyastheniagravis
AT sindychai repetitivenervestimulationasapredictoroftreatmentresponseinmyastheniagravis
AT rezastevano repetitivenervestimulationasapredictoroftreatmentresponseinmyastheniagravis